Skyrizi 360 mg

SKYRIZI 360 MG is a subcutaneous solution containing risankizumab, used for managing moderate to severe plaque psoriasis. This biologic medication helps reduce inflammation and improve skin condition.

SKYRIZI 360 MG is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Risankizumab works by targeting specific proteins in the body to reduce inflammation and slow down skin cell turnover. People often ask, 'What is SKYRIZI used for?' and the answer is that it is designed to help manage symptoms of plaque psoriasis, including red, itchy, and scaly patches on the skin.

Common effects of SKYRIZI 360 MG may include reactions at the injection site, such as redness, itching, or pain. Some users might experience upper respiratory infections, headache, or fatigue. These effects vary and are not experienced by everyone.

SKYRIZI 36I MG should be handled with care, following the instructions provided by a healthcare professional. It is important to store the medication properly and to use it exactly as directed. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

SKYRIZI 360 MG may interact with other medications, including biologics or immunosuppressants. It is important to discuss all current medications with a healthcare provider to ensure safe use. Alcohol and certain foods may also affect how the body responds to risankizumab.